Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial
Arthritis & Rheumatism, 11/06/09
Koffeman EC et al. – Tolerization to dnaJP1 leads to immune deviation and a trend toward clinical efficacy. Susceptibility to treatment relies on the coexpression of molecules that can down-regulate adaptive immunity.
Methods- Pilot phase II trial
- 160 patients with active RA and immunologic reactivity to dnaJP1
- dnaJP1 peptide safe and well-tolerated
- Significant reduction in percentage of T cells producing tumor necrosis factor and corresponding trend toward increased percentage of T cells producing interleukin-10
- Coexpression of cluster of molecules (programmed death 1 and its ligands) associated with T cell regulation also found to be a prerequisite for successful tolerization in clinical responders
- Analysis of primary efficacy end point (meeting the American College of Rheumatology 20% improvement criteria at least once on day 112, 140, or 168) showed difference between treatment groups that became significant in post hoc analysis using generalized estimating equations
- Differences in clinical responses also found between treatment groups on day 140 and followup
- Post hoc analysis showed that combination of dnaJP1 and hydroxychloroquine (HCQ) was superior to combination of HCQ and placebo
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Immunocytokines: the long-awaited therapeutic magic bullet in rheumatoid arthritis
Arthritis Research & Therapy, 11/23/09
Effect of Sildenafil on digital ulcers in systemic sclerosis - analysis from a single centre pilot study
Annals of Rheumatic Diseases, 11/22/09
Prescription and comorbidity screening following consultation for acute gout in primary care
Rheumatology, 11/21/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
No evidence for association of the KLF12 gene with RA in a large UK cohort of >7,000 samples.
Annals of Rheumatic Diseases, 11/23/09
Immunocytokines: the long-awaited therapeutic magic bullet in rheumatoid arthritis
Arthritis Research & Therapy, 11/23/09
Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis
Annals of Rheumatic Diseases, 11/22/09
Sponsor
Article Search
Sponsor


See Latest Articles


